Skip to main content
Premium Trial:

Request an Annual Quote

Laying Out the Map

The Ohio State University has a white paper on personalized medicine that discusses the university's model for employing personalized medicine at its medical center. OSU will be taking a four-stage approach -- from discovery, particularly using a systems-based approach, to developing preclinical trials and experimental therapeutics to then implementing those new strategies, and finally to disease prevention strategies. The paper adds that to make personalized medicine a reality, support is needed from the federal and state levels. "We urge our legislative leaders and public officials to support the development of personalized health care as a long-term strategy in transforming health care in the United States," the paper says.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.